NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Exercise-Induced Irisin and Brain Changes
Exercise-Induced Irisin and Brain Changes

NCT07101653

CompletedNA

Sponsor: Firat University

Conditions: Multiple Sclerosis

Interventions: Exercise

Countries: Turkey (Türkiye)

This single-blind, randomized controlled trial will employ a two-arm parallel design (exercise group vs. control group) with a 12-week intervention period. Sex-stratified randomization will be implemented using SPSS 25.0 (IBM Corporation, Armonk, NY, USA) to ensure balanced group allocation. All outcome measures will be assessed at baseline and post-intervention.

Eligibility overview

Sex: ALL

Age: 19 Years to 65 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Clinically confirmed relapsing-remitting multiple sclerosis (RRMS) diagnosis according to revised McDonald criteria (2017)
* Aged 19-65 years (inclusive)
* Mild-to-moderate disability (EDSS score 1.0-5.5)
* No corticosteroid treatment within the previous 3 months

Exclusion Criteria:

* Acute MS relapse within 90 days prior to enrollment
* Regular participation in structured exercise programs (\>3 hours/week)
* Comorbid conditions that may limit exercise participation, including; significant orthopedic impairments, unstable cardiopulmonary conditions and other systemic disorders affecting physical activity
* Standard MRI contraindications (metallic implants, claustrophobia, etc.)
* Concurrent neurological disorders (other than MS)
* Initiation or modification of disease-modifying therapy within 6 months
* Severe spasticity (Modified Ashworth Scale ≥3 in any major muscle group)
Locations (1)
  • Elâzığ, Turkey (Türkiye)